(Q82663605)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16501925%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

[Systemic lupus erythematosus--activity and outcome] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16501925%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

17 January 2020

main subject

0 references

author

Martin Aringer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16501925%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

J Smolen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16501925%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16501925%20AND%20SRC:MED&resulttype=core&format=json

Zeitschrift fuer Rheumatologie

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16501925%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16501925%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16501925%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

103-6, 108-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16501925%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00393-006-0040-9

17 January 2020

exact match

0 references

cites work

Assessing disease activity in SLE patients during pregnancy

1 reference

12 December 2020

A statistical analysis of the interrelationships between disease activity in different systems in systemic lupus erythematosus

1 reference

12 December 2020

Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study

1 reference

12 December 2020

Classification and definition of major flares in SLE clinical trials

1 reference

12 December 2020

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

1 reference

12 December 2020

A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE).

1 reference

12 December 2020

Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus

1 reference

12 December 2020

Sequential therapies for proliferative lupus nephritis

1 reference

12 December 2020

Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention

1 reference

12 December 2020

Outcome criteria for lupus nephritis trials: a critical overview

1 reference

12 December 2020

The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set

1 reference

12 December 2020

Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only

1 reference

12 December 2020

Maintenance therapy for lupus nephritis--something old, something new.

1 reference

12 December 2020

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

1 reference

12 December 2020

Outcome measures to be used in clinical trials in systemic lupus erythematosus

1 reference

12 December 2020

Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of

1 reference

12 December 2020

Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics.

1 reference

12 December 2020

Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades

1 reference

12 December 2020

Mortality and causes of death in systemic lupus erythematosus.

1 reference

12 December 2020

B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab

1 reference

12 December 2020

Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis.

1 reference

12 December 2020

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

12 December 2020

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

12 December 2020

The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera

1 reference

12 December 2020

Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group.

1 reference

12 December 2020

Severe infections in plasmapheresis-treated systemic lupus erythematosus

1 reference

12 December 2020

Biomarkers in systemic lupus erythematosus: II. Markers of disease activity

1 reference

12 December 2020

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus

1 reference

12 December 2020

"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis.

1 reference

12 December 2020

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

1 reference

12 December 2020

The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus.

1 reference

12 December 2020

Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus

1 reference

12 December 2020

The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity

1 reference

12 December 2020

Systemic lupus erythematosus disease activity index 2000

1 reference

12 December 2020

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

1 reference

12 December 2020

A study of fatigue in systemic lupus erythematosus

1 reference

12 December 2020

The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity

1 reference

12 December 2020

Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology

1 reference

12 December 2020

Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.

1 reference

12 December 2020

Fatigue in patients with lupus is not associated with disturbances in cerebral blood flow as detected by SPECT.

1 reference

12 December 2020

The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison

1 reference

12 December 2020

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

1 reference

12 December 2020

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

1 reference

12 December 2020

Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activ

1 reference

12 December 2020

Fatigue in lupus is not correlated with disease activity.

1 reference

12 December 2020

IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study

1 reference

12 December 2020